News Breaks |
|
|
| February 17, 2013 |
| 12:46 EDT |  | GILD | Gilead Issues a voluntary recall of one lot of Vistide
Gilead Sciences announced it is voluntarily recalling lot B120217A of Vistide (cidofovir injection) to the user level due to the presence of particulate matter found in some vials of this lot. Effects from intravenous injection of product with particulate matter can vary depending on the amount of particulate matter injected into the patient, the size of the particles and the patient’s underlying medical condition, and can be severe. Gilead is not currently aware of any complaint attributable to the particles. |
|
|
News For GILD From The Last 14 Days Check below for free stories on GILD the last two weeks. |
|
|
| May 21, 2013 |
| 16:51 EDT | | GILD | Gilead's sofosbuvir gets EMA validation, now under assessment
 Subscribe for More Information |
|
| May 20, 2013 |
| 07:34 EDT |  | GILD | UBS to host a conference
Subscribe for More Information |
|
| May 16, 2013 |
| 11:50 EDT | | GILD | Celgene, Gilead lower after new data published at ASCO
Subscribe for More Information |
|
| May 15, 2013 |
| 18:32 EDT | | GILD | Gilead announces response data from Phase 2 study of Idelalisib
Subscribe for More Information |
|
| May 13, 2013 |
| 09:39 EDT |  | GILD | Active equity option families trading
Active equity option families trading on open according to Track Data: AAPL C TSLA LVS GILD FSLR |
|
|
|
|
|
